RecruitingPHASE1, PHASE2NCT05894824

T-Dxd in Combination With Ramucirumab as HER2 Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Studying Anorectal malformation

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Yonsei University
Principal Investigator
SUN YOUNG RHA
Yonsei Cancer Center, Yonsei University College of Medicine
Intervention
T-Dxd(Trastuzmab deruxtecan), Ramucirumab(drug)
Enrollment
58 target
Eligibility
19 years · All sexes
Timeline
2024 – 2026

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05894824 on ClinicalTrials.gov

Other trials for Anorectal malformation

Additional recruiting or active studies for the same condition.

See all trials for Anorectal malformation →

← Back to all trials